Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...

Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version of Novo ...

Both drugs come as an injection. Ozempic and Victoza are not available as generic drugs. This article explains the main ways that Ozempic and Victoza are alike and different. For more information ...

Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Novo said Teva could launch its generic earlier, but not before March of 2023, unless the Victoza patents are no longer in force or there is another generic on the market.

Eli Lilly and Novo Nordisk enjoy the highest values in the pharma sector, as investors expect years of high-volume, ...

Hims & Hers anticipates selling a generic version of NVO's liraglutide, threatening sales as soon as next year. Intense competition from Viking Therapeutics and Amgen, may result in a new best in ...

Denmark-based Novo Nordisk teased some new details about a potential Ozempic successor during a call with investors on Tuesday. Sales of the company’s current blockbuster weight loss drug, Wegovy, ...

If you click on links we provide, we may receive compensation. Our winner was the Frisco Wire Dog & Small Pet Exercise Pen with Step-Through Door In This Article Our Top Picks People / Jhett ...